Order Vacating Preliminary Injunction on LEQSELVI™

On 09 April 2025, the U.S. Court of Appeals for the Federal Circuit held an oral argument on Sun Pharmaceutical Industries Limited's appeal of the U.S. District Court for the District of New Jersey's decision that previously granted a preliminary injunction delaying the Company's launch of LEQSELVI™ (deuruxolitinib) in the United States. Shortly after the oral argument concluded, on 09 April 2025, the U.S. Court of Appeals for the Federal Circuit ruled in favour of the Company and vacated the preliminary injunction effective immediately. While the litigation between Incyte Corporation and the Company continues, the preliminary injunction is no longer in effect.

The Company is no longer under a court order that delays or restricts the Company from launching LEQSELVI™. The Company will disclose LEQSELVI™ launch plans in due course of time.

Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 1652.10 as compared to the previous close of Rs. 1688.75. The total number of shares traded during the day was 58139 in over 5480 trades.

The stock hit an intraday high of Rs. 1679.55 and intraday low of 1645.00. The net turnover during the day was Rs. 96812370.00.

Source : Equity Bulls

Keywords

SunPharmaceuticalIndustries INE044A01036 PreliminaryInjunction Vacated LEQSELVI deuruxolitinib US